A

Aptose Biosciences

APTO

0.52320
USD
-0.0368
(-6.57%)
Market Closed
Volume
4,042
EPS
0
Div Yield
0
P/E
-0
Market Cap
6,861,649
Related Instruments
AZN
2.040
(2.58%)
81.200 USD
B
BNTX
-5.530
(-6.42%)
80.570 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
PFE
0.115
(0.38%)
30.650 USD
V
VXRT
-0.01170
(-1.74%)
0.65890 USD
News

Title: Aptose Biosciences

Sector: Healthcare
Industry: Biotechnology
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.